e-4824 (Health)
- Keywords
- Lung cancer
- Pharmaceuticals
Original language of petition: English
Petition to the House of Commons
- Lung cancer has the highest mortality rate of all cancers in Canada and is increasingly diagnosed in non-smokers with no other risk factors;
- Patients are increasingly diagnosed at the late stages of cancer and thus are limited in treatment plans and are sometime given only weeks-months left to live;
- Delays to accessing new treatments do not help, particularly as lung cancer research receives limited funding compared to other cancers in Canada; and
- We need your support to ensure that all Canadians have access to the best available treatments. Canadians are faced with significant barriers in accessing their prescribed cancer treatments: which province they live in, paying out-of-pocket costs or travel to other countries to receive care when Canada is so behind on approving the newest protocols approved by the FDA.
- Open for signature
- February 29, 2024, at 10:45 a.m. (EDT)
- Closed for signature
- May 29, 2024, at 10:45 a.m. (EDT)